| Ident. | Authors (with country if any) | Title |
|---|
| 001C04 (2006) |
Giovanni Lagalla [Italie] ; Marzia Millevolte [Italie] ; Marianna Capecci [Italie] ; Leandro Provinciali [Italie] ; Maria Gabriella Ceravolo [Italie] | Botulinum toxin type a for drooling in Parkinson's disease : A double-blind, randomized, placebo-controlled study |
| 001E55 (2005) |
Adrian Cristian [États-Unis] ; Meredith Katz [États-Unis] ; Eileen Cutrone [États-Unis] ; Ruth H. Walker [États-Unis] | Evaluation of acupuncture in the treatment of Parkinson's disease : A double-blind pilot study |
| 001E58 (2005) |
Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients : A pharmacokinetic/pharmacodynamic, randomized, double-blind study |
| 001E62 (2005) |
Daniel Truong [États-Unis] ; Drake D. Duane [États-Unis] ; Joseph Jankovic [États-Unis] ; Carlos Singer [États-Unis] ; Lauren C. Seeberger [États-Unis] ; Cynthia L. Comella [États-Unis] ; Mark F. Lew [États-Unis] ; Robert L. Rodnitzky [États-Unis] ; Fabio O. Danisi [États-Unis] ; James P. Sutton [États-Unis] ; P. David Charles [États-Unis] ; Robert A. Hauser [États-Unis] ; Geoffrey L. Sheean [États-Unis] | Efficacy and safety of botulinum type A toxin (dysport) in cervical dystonia : Results of the first us randomized, double-blind, placebo-controlled study |
| 002061 (2004) |
Karin Stiasny-Kolster [Allemagne] ; Ralf Kohnen [Allemagne] ; Erwin Schollmayer [Allemagne] ; J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne] | Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of Restless Legs Syndrome: A double-blind, placebo-controlled pilot study |
| 002343 (2003) |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor |
| 002344 (2003) |
Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon] ; Kazuko Hasegawa [Japon] ; Hideki Origasa [Japon] ; Hisayuki Kowa [Japon] | Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease |
| 002345 (2003) |
Charles H. Adler [États-Unis] ; John N. Caviness [États-Unis] ; Joseph G. Hentz [États-Unis] ; Marlene Lind [États-Unis] ; Judy Tiede [États-Unis] | Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease |
| 002387 (2003) |
Claudia Trenkwalder [Allemagne] ; Victor Collado Seidel [Allemagne] ; Jörg Kazenwadel [Suisse] ; Thomas C. Wetter [Allemagne] ; Wolfgang Oertel [Allemagne] ; Roland Selzer [Allemagne] ; Ralf Kohnen [Allemagne] | One-year treatment with standard and sustained-release levodopa: Appropriate long-term treatment of restless legs syndrome? |
| 002406 (2003) |
Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] | Mirtazapine in essential tremor: A double-blind, placebo-controlled pilot study |
| 002419 (2003) |
Jau-Shin Lou [États-Unis] ; Greg Kearns [États-Unis] ; Theodore Benice [États-Unis] ; Barry Oken [États-Unis] ; Gary Sexton [États-Unis] ; John Nutt [États-Unis] | Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study |
| 002467 (2003) |
Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of Piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6-month, randomized, placebo-controlled study |
| 002477 (2003) |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest Tremor and UPDRS part III in Parkinson's disease |
| 002478 (2003) |
Francesca Mancini [Italie] ; Roberta Zangaglia [Italie] ; Silvano Cristina [Italie] ; Maria Grazia Sommaruga [Italie] ; Emilia Martignoni [Italie] ; Giuseppe Nappi [Italie] ; Claudio Pacchetti [Italie] | Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of Drooling in parkinsonism |
| 002630 (2002) |
Susan H. Fox [Royaume-Uni] ; Mark Kellett [Royaume-Uni] ; A. Peter Moore [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia |
| 002843 (2002) |
C. Detrembleur [Belgique] ; T. M. Lejeune [Belgique] ; A. Renders [Belgique] ; P. Y. K. Van Den Bergh [Belgique] | Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy |
| 002884 (2001) |
J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis] | Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled study |
| 002966 (2001) |
Fabrizio Stocchi [Italie] ; Laura Vacca [Italie] ; Alfredo Berardelli [Italie] ; Francesca De Pandis [Italie] ; Stefano Ruggieri [Italie] | Long-duration effect and the postsynaptic compartment : Study using a dopamine agonist with a short half-life |
| 002973 (2001) |
Paolo Del Dotto [Italie] ; Nicola Pavese [Italie] ; Gianna Gambaccini [Italie] ; Silvia Bernardini [Italie] ; Leonard Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Ubaldo Bonuccelli [Italie] | Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study |
| 002A33 (2001) |
Stewart A. Factor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Margaret C. Lannon [États-Unis] ; David Oakes [États-Unis] ; Keith Bourgeois [États-Unis] | Clozapine for the treatment of drug-induced psychosis in Parkinson's disease : Results of the 12 week open label extension in the PSYCLOPS trial |
| 002C00 (2000) |
W. Ondo [États-Unis] ; C. Hunter [États-Unis] ; K. Dat Vuong [États-Unis] ; K. Schwartz [États-Unis] ; Joseph Jankovic [États-Unis] | Gabapentin for Essential tremor : A multiple-dose, double-blind, placebo-controlled trial |
